Brief: Active Biotech Q4 Operating Loss Sek 7.1 Million
Feb 14 (Reuters) - Active Biotech AB ACTI.ST :
* Q4 NET SALES SEK 4.8 MILLION VERSUS SEK 5.4 MILLION YEAR AGO
* Q4 OPERATING LOSS SEK 7.1 MILLION VERSUS LOSS SEK 58.4 MILLION YEAR AGO
Source text for Eikon: ID:nGNE1jS8fl
Further company coverage: ACTI.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million